I recently ran across a couple of things about gut bacteria that I thought were interesting. The first involves the use of piperine (an extract of black pepper) to keep l-dopa from being converted to dopamine by bacteria in the small intestine, leaving more to travel to the brain;
onlinelibrary.wiley.com/doi...
"Tyrosine decarboxylase (TDC) presented in the gut-associated strain Enterococcus faecalis can convert levodopa (L-dopa) into dopamine (DA), and its increased abundance would potentially minimize the availability and efficacy of L-dopa. However, the known human decarboxylase inhibitors are ineffective in this bacteria-mediated conversion. This study aims to investigate the inhibition of piperine (PIP) on L-dopa bacterial metabolism and evaluates the synergistic effect of PIP combined with L-dopa on Parkinson's disease (PD)."
"We found that PIP combined with L-dopa could better ameliorate the move disorders of 6-OHDA-lesioned rats by remarkably improving L-dopa availability and brain DA level than L-dopa alone, which was associated with the effect of PIP on suppressing the bacterial decarboxylation of L-dopa via effectively downregulating the abnormal high abundances of E. faecalis and TDC in 6-OHDA-lesioned rats."
The second story involves gut bacteria as well, but this time as a possibly promising treatment; researchers apparently engineered a probiotic bacteria that can synthesize L-dopa. Testing in animals showed that it can achieve consistent L-DOPA levels in blood plasma and steady brain dopamine levels without any unwanted fluctuation. When a paper on the subject was presented in 2022, the authors said they were seeking FDA approval for clinical trials. eurekalert.org/news-release...